MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
Safi G AlqatariPeter RiddellSinead HarneyMichael HenryGrainne MurphyPublished in: BMC pulmonary medicine (2018)
This case highlights a number of considerations in approaching patients with inflammatory myositis, particularly to pulmonary involvement. It is important to highlight the utility of extended myositis antibody testing in predicting disease phenotypes and its impact on therapeutic decisions. From a management perspective, aggressive immunosuppression should be considered with potential need of earlier utilization of ECMO.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- extracorporeal membrane oxygenation
- multiple sclerosis
- pulmonary hypertension
- acute respiratory distress syndrome
- breast cancer cells
- oxidative stress
- human health
- cell death
- cell cycle arrest
- intensive care unit
- climate change